AKRO logo

Akero Therapeutics (AKRO) Cash from investing

annual CFI:

-$109.71M+$113.92M(+50.94%)
December 31, 2024

Summary

  • As of today (July 1, 2025), AKRO annual cash flow from investing activities is -$109.71 million, with the most recent change of +$113.92 million (+50.94%) on December 31, 2024.
  • During the last 3 years, AKRO annual CFI has fallen by -$151.99 million (-359.48%).
  • AKRO annual CFI is now -359.48% below its all-time high of $42.28 million, reached on December 31, 2021.

Performance

AKRO Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROcash flow metrics

quarterly CFI:

-$482.18M-$497.45M(-3257.30%)
March 31, 2025

Summary

  • As of today (July 1, 2025), AKRO quarterly cash flow from investing activities is -$482.18 million, with the most recent change of -$497.45 million (-3257.30%) on March 31, 2025.
  • Over the past year, AKRO quarterly CFI has dropped by -$540.03 million (-933.52%).
  • AKRO quarterly CFI is now -759.92% below its all-time high of $73.07 million, reached on September 30, 2024.

Performance

AKRO quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROcash flow metrics

TTM CFI:

-$649.74M-$540.03M(-492.24%)
March 31, 2025

Summary

  • As of today (July 1, 2025), AKRO TTM cash flow from investing activities is -$649.74 million, with the most recent change of -$540.03 million (-492.24%) on March 31, 2025.
  • Over the past year, AKRO TTM CFI has dropped by -$466.38 million (-254.34%).
  • AKRO TTM CFI is now -1047.78% below its all-time high of $68.55 million, reached on June 30, 2022.

Performance

AKRO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AKRO Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+50.9%-933.5%-254.3%
3 y3 years-359.5%-2219.5%-1511.6%
5 y5 years-53.4%-7576.9%-1552.1%

AKRO Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-359.5%+50.9%-759.9%at low-1047.8%at low
5 y5-year-359.5%+50.9%-759.9%at low-1047.8%at low
alltimeall time-359.5%+50.9%-759.9%at low-1047.8%at low

AKRO Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$482.18M(-3257.3%)
-$649.74M(+492.2%)
Dec 2024
-$109.71M(-50.9%)
$15.27M(-79.1%)
-$109.71M(-2.2%)
Sep 2024
-
$73.07M(-128.6%)
-$112.19M(-63.9%)
Jun 2024
-
-$255.90M(-542.4%)
-$310.96M(+69.6%)
Mar 2024
-
$57.85M(+352.4%)
-$183.36M(-18.0%)
Dec 2023
-$223.62M(+250.4%)
$12.79M(-110.2%)
-$223.62M(-33.8%)
Sep 2023
-
-$125.70M(-2.0%)
-$337.85M(+61.5%)
Jun 2023
-
-$128.30M(-829.4%)
-$209.16M(+203.2%)
Mar 2023
-
$17.59M(-117.3%)
-$68.98M(+8.1%)
Dec 2022
-$63.83M(-251.0%)
-$101.44M(-3481.5%)
-$63.83M(-228.6%)
Sep 2022
-
$3.00M(-74.7%)
$49.62M(-27.6%)
Jun 2022
-
$11.87M(-47.8%)
$68.55M(+48.9%)
Mar 2022
-
$22.75M(+89.6%)
$46.03M(+8.9%)
Dec 2021
$42.28M
$12.00M(-45.3%)
$42.28M(-12.2%)
DateAnnualQuarterlyTTM
Sep 2021
-
$21.93M(-305.9%)
$48.18M(-243.4%)
Jun 2021
-
-$10.65M(-156.1%)
-$33.60M(-316.5%)
Mar 2021
-
$19.00M(+6.2%)
$15.52M(-259.0%)
Dec 2020
-$9.76M(-86.4%)
$17.90M(-129.9%)
-$9.76M(-90.2%)
Sep 2020
-
-$59.84M(-255.6%)
-$99.17M(+152.2%)
Jun 2020
-
$38.47M(-712.4%)
-$39.33M(-49.4%)
Mar 2020
-
-$6.28M(-91.2%)
-$77.79M(+8.8%)
Dec 2019
-$71.51M(+1330.3%)
-$71.51M(<-9900.0%)
-$71.51M(<-9900.0%)
Sep 2019
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2019
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2019
-
$0.00(0.0%)
-$5.00M(0.0%)
Dec 2018
-$5.00M
$0.00(0.0%)
-$5.00M(0.0%)
Sep 2018
-
$0.00(-100.0%)
-$5.00M(0.0%)
Jun 2018
-
-$5.00M
-$5.00M

FAQ

  • What is Akero Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Akero Therapeutics?
  • What is Akero Therapeutics annual CFI year-on-year change?
  • What is Akero Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Akero Therapeutics?
  • What is Akero Therapeutics quarterly CFI year-on-year change?
  • What is Akero Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Akero Therapeutics?
  • What is Akero Therapeutics TTM CFI year-on-year change?

What is Akero Therapeutics annual cash flow from investing activities?

The current annual CFI of AKRO is -$109.71M

What is the all time high annual CFI for Akero Therapeutics?

Akero Therapeutics all-time high annual cash flow from investing activities is $42.28M

What is Akero Therapeutics annual CFI year-on-year change?

Over the past year, AKRO annual cash flow from investing activities has changed by +$113.92M (+50.94%)

What is Akero Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of AKRO is -$482.18M

What is the all time high quarterly CFI for Akero Therapeutics?

Akero Therapeutics all-time high quarterly cash flow from investing activities is $73.07M

What is Akero Therapeutics quarterly CFI year-on-year change?

Over the past year, AKRO quarterly cash flow from investing activities has changed by -$540.03M (-933.52%)

What is Akero Therapeutics TTM cash flow from investing activities?

The current TTM CFI of AKRO is -$649.74M

What is the all time high TTM CFI for Akero Therapeutics?

Akero Therapeutics all-time high TTM cash flow from investing activities is $68.55M

What is Akero Therapeutics TTM CFI year-on-year change?

Over the past year, AKRO TTM cash flow from investing activities has changed by -$466.38M (-254.34%)
On this page